Patients Who Receive Androgen Deprivation Therapy Risk Adverse Cognitive Changes.
University of Queensland Centre for Clinical Research and Royal Brisbane and Women's Hospital, Brisbane, Queensland; and Edith Cowan University, Joondalup, Western Australia, Australia f.gardiner@uq.edu.au.
Robert A
RA
Gardiner
Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
John
J
Yaxley
University of Queensland, Brisbane, Queensland, Australia.
Kenneth I
KI
Pakenham
Griffith University, Brisbane, Queensland, Australia.
Heather
H
Green
Queen Elizabeth II Hospital, Brisbane, Queensland, Australia.
Peter
P
Mactaggart
Mater Hospitals, Brisbane, Queensland, Australia.
Roger
R
Watson
University of Queensland, Brisbane, Queensland, Australia.
Cheryl
C
Swanson
Royal Marsden Hospital, London, United Kingdom.
David L
DL
Nicol
D000726:Androgen Antagonists / Q000627:therapeutic use*; D003072:Cognition Disorders / Q000150:complications*; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000150:complications* / Q000628:therapy*
D000726:Androgen Antagonists